CollPlant Biotechnologies Receivables

CollPlant Biotechnologies (CLGN) currently reports a receivables of $230K as of March 2026. That compares with $440K in the prior-year period — down 47.0% year over year. Use the charts on this page to explore CollPlant Biotechnologies's receivables history and peer comparisons.

CollPlant Biotechnologies's receivables decreased from $440K to $230K — a 47.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CollPlant Biotechnologies reported $230K in receivables as of March 2026. That compares with $440K in the prior-year period — down 47.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $230K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CollPlant Biotechnologies, and consider following CLGN for alerts when major investors trade the stock.

CollPlant Biotechnologies is classified in the Healthcare sector. On receivables, it currently shows $230K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLGN with unrelated industries.